News

With the acquisition, UPS will be able to strengthen its healthcare expertise and network in Europe and enable compliant logistics services to customers to help them stream their

Launched after the completion of the iv clinical development programme, posaconazole concentrate for solution for iv provides another option for treatment of fungal infections in critically ill patients

The acquisition of the over-the-counter nicotine replacement therapy transdermal patch was completed last month following issuance of the proposed consent order from the US Federal Trade Commission (FTC).

Velcade covers use of bortezomib along with rituximab, cyclophosphamide, doxorubicin and prednisone for the treatment of adult patients with previously untreated MCL, who are unsuitable for haematopoietic stem

Sibutramine is an appetite suppressant that was withdrawn from the U.S. market in October 2010 (due to increased risk of seizures, heart attacks, arrhythmia and strokes). Phenolphthalein is

Nuvilex’s pancreatic cancer treatment combines Nuvilex’s patented and proprietary cellulose-based encapsulation technology, known as Cell-in-a-Box(R), with the cancer prodrug ifosfamide and encapsulated live cells that convert the prodrug

As part of the deal, OncoEthix will receive an upfront payment of up to $110m from Merck. Upon certain clinical and regulatory events being achieved, OncoEthix will also

Todd C. Brady, M.D., Ph.D., President and CEO of Aldeyra, commented, "The submission of an IND for NS2 in the treatment of noninfectious anterior uveitis is a major

The collaborators will use Enumeral’s human approach to interrogating the tumor microenvironment in colorectal cancer tissues obtained directly from patients in order to identify functional cellular responses to